TrialAIDS research and human retroviruses2013

Inflammatory biomarker changes and their correlation with Framingham cardiovascular risk and lipid changes in antiretroviral-naive HIV-infected patients treated for 144 weeks with abacavir/lamivudine/atazanavir with or without ritonavir in ARIES.

Benjamin Young et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.